ClinicalTrials.gg
Not yet recruitingNCT07914153STAPOUpdated Nov 3, 2026

Early Functional Outcomes After Open Versus Percutaneous Repair of Acute Achilles Tendon Ruptures

An interventional study of Percutaneous Surgical Repair of Acute Achilles Tendon Rupture and Open Surgical Repair of Acute Achilles Tendon Rupture in Patients With an Acute Achilles Tendon Rupture and Time From Achilles Tendon Rupture to Surgery of Less Than 2 Weeks, sponsored by University Hospital, Strasbourg, France. Not yet recruiting at 1 site in France. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by University Hospital, Strasbourg, France · Not applicable, Interventional, and Treatment

Updated Nov 3, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

This study aims to compare early functional outcomes and postoperative complications following open versus percutaneous repair of acute Achilles tendon ruptures in patients younger than 55 years admitted to Hautepierre Hospital. It will assess whether percutaneous repair reduces skin-related complications and whether open repair provides better early muscle strength recovery.

Read the detailed description

Acute Achilles tendon rupture is a common injury that may require surgical treatment. Two main surgical techniques are used: open repair and percutaneous repair. Although both aim to restore tendon continuity and function, they may differ in terms of postoperative complications, muscle strength recovery, and functional rehabilitation.

The aim of this study is to compare early functional outcomes and postoperative complications following open versus percutaneous surgical repair of acute Achilles tendon ruptures. The study hypothesizes that percutaneous repair may reduce skin-related complications, including delayed wound healing and surgical site infection, whereas open repair may provide better early recovery of muscle strength and facilitate rehabilitation.

The study will include patients younger than 55 years admitted to Hautepierre Hospital with an acute Achilles tendon rupture who meet the eligibility criteria and have no predefined exclusion criteria. The findings may help determine whether one surgical technique offers advantages over the other and contribute to optimizing the management of acute Achilles tendon ruptures.

02

Conditions studied

  • Patients With an Acute Achilles Tendon Rupture
  • Time From Achilles Tendon Rupture to Surgery of Less Than 2 Weeks

Keywords

  • acute Achilles tendon rupture
03

In context

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 999 studies on the registry; 358 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Male or female patients aged 18 to 55 years, inclusive.

Patients with an Achilles tendon rupture diagnosed clinically and confirmed by imaging (ultrasound or magnetic resonance imaging [MRI]) when necessary.

Patients for whom surgical management has been decided by a multidisciplinary trauma team meeting.

Time between Achilles tendon rupture and surgery of less than 2 weeks.

Patients able to understand the objectives and risks of the study and to provide dated and signed informed consent.

Patients affiliated with, or beneficiaries of, a social security system.

Exclusion criteria

Exclusion Criteria:

Corticosteroid or platelet-rich plasma (PRP) injection in the vicinity of the Achilles tendon within 6 months before the Achilles tendon rupture.

Chronic Achilles tendinopathy.

History of a previous nonoperatively treated ipsilateral Achilles tendon rupture.

History of ipsilateral Achilles tendon surgery.

Use of a walking aid before the Achilles tendon rupture.

American Society of Anesthesiologists (ASA) Physical Status Classification of III or higher.

Skin lesions in the surgical area (e.g., open wounds or abrasions).

Inability to speak either English or French.

Achilles tendon laceration caused by a sharp object.

Patients under judicial protection or subject to a guardianship or curatorship measure.

Inability to provide informed consent (e.g., emergency circumstances or difficulties understanding the study information).

Patients subject to a legal protection measure, including curatorship, guardianship, a future protection mandate, or family authorization.

Patients currently within an exclusion period from a previous study.

Psychiatric disorders.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Percutaneous Surgical Repair

    Participants with an acute Achilles tendon rupture randomized to undergo percutaneous surgical repair.

    Procedure: Percutaneous Surgical Repair of Acute Achilles Tendon Rupture

  • Active comparator
    Open Surgical Repair

    Participants with an acute Achilles tendon rupture randomized to undergo open surgical repair.

    Procedure: Open Surgical Repair of Acute Achilles Tendon Rupture

Interventions

  • ProcedurePercutaneous Surgical Repair of Acute Achilles Tendon Rupture

    Surgical repair of an acute Achilles tendon rupture using a percutaneous technique.

  • ProcedureOpen Surgical Repair of Acute Achilles Tendon Rupture

    Surgical repair of an acute Achilles tendon rupture using an open surgical technique.

06

What researchers measure

Primary outcomes

  1. Change in Achilles Tendon Total Rupture Score (ATRS) From 3 to 6 Months Postoperatively

    The Achilles Tendon Total Rupture Score (ATRS) is a validated patient-reported outcome measure assessing symptoms and physical activity limitations following Achilles tendon rupture. The score ranges from 0 to 100 points, with higher scores indicating fewer symptoms and better function. The change in score will be calculated as the 6-month score minus the 3-month score and compared between the percutaneous surgery and open surgery groups.

    Time frame: 3 months and 6 months postoperatively.

  2. Change in European Foot and Ankle Society (EFAS) Score From 3 to 6 Months Postoperatively

    The European Foot and Ankle Society (EFAS) score is a patient-reported outcome measure assessing foot and ankle function. The score will be recorded using the questionnaire version specified in the study protocol, with a total score ranging from 0 to 40 points according to the study questionnaire. Higher scores indicate better function, provided this is consistent with the scoring instructions for the version used. The change in score will be calculated as the 6-month score minus the 3-month score and compared between the percutaneous surgery and open surgery groups.

    Time frame: 3 months and 6 months postoperatively.

  3. Change in Return to Sport after Injury (RSI) Score From 3 to 6 Months Postoperatively

    Psychological readiness to return to sport will be assessed using a 12-item patient-reported questionnaire administered at 3 and 6 months postoperatively. Each item is rated from 0 to 10, giving a maximum raw total score of 120 points. Higher scores indicate greater psychological readiness to return to sport. The change in score will be calculated as the 6-month score minus the 3-month score and compared between patients undergoing percutaneous surgery and those undergoing open surgery.

    Time frame: 3 months and 6 months postoperatively

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — No individual participant data will be shared. Study results may be disseminated through scientific publications and presentations, without disclosing personally identifiable information.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Nov 2028, 24 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 27, 2026
First posted
Nov 3, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Nov 30, 2028
CompletionEst.
Nov 30, 2028
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07914153
Responsible party
Sponsor
First posted
Nov 3, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Nov 30, 2028 (estimated)
Completion
Nov 30, 2028 (estimated)
Last update
Nov 3, 2026

Study contacts

Monia BEN HADJ HAMED
Contact
monia.ben-hadj-hamed@chru-strasbourg.fr
+33(0)3 88 11 67 11
Henri FAVREAU, Doctor
principal investigator · Hôpitaux Universitaires de Strasbourg

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion